Evaluation of Injectable Beta-tricalcium Phosphate Clinically in Treatment of Grade II Furcation Involvement

Hams Hamed Abdelrahman

Status: Completed

Conditions: Furcation Defects

Treatments: Other: Hydroxyapatite bone graft; Other: PD VitalOs cement®; Other: biodegardable collagen membrane

Study type: Interventional

Funder types: Other

Identifiers

NCT04443972

Furcation invlvement

Details and patient eligibility

About

This study will be conducted to evaluate clinically and radiographically the use of PD VitalOs cement® bone graft in the treatment of class II furcation defects comparing with Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Full description

The study is a randomized, controlled clinical trial. Patients were randomly divided into two equal groups, Group I (Test group): included seven Grade II furcation defects treated by beta tricalcium phosphate bone cement only.

Group II (Control group): included seven Grade II furcation defects treated with granulated beta tricalcium phosphate bone graft covered by resorbable collagen membrane.

Enrollment: 14 patients

Sex: All

Ages: 30 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• • Presence of a lower molar with critical size grade II furcation defect (15) with a horizontal component of 4 mm and a vertical component of 4 to 6 mm (18), detected using Naber's probe and William's periodontal probe.

  • Patient's age between 30 - 50 years.
  • Both sexes.
  • The patient should be psychologically accepting the procedures.
  • Patients should be systemically free.

Exclusion criteria

• • Uncooperative patients regarding oral hygiene measures performance.

  • Patients with para functional habits.
  • Smokers.
  • Pregnant or lactating women.
  • Patients who underwent any periodontal surgeries in the study site during the six months prior to study.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

14 participants in 2 patient groups

PD VitalOs cement® alone

Experimental group

Description:

class II furcation defects that will be treated with PD VitalOs cement® alone

Treatment:

Other: PD VitalOs cement®

PD VitalOs cement® plus Bone graft and membrane

Experimental group

Description:

PD VitalOs cement® and Hydroxyapatite bone graft and biodegradable collagen membrane in the treatment of class II furcation defects.

Treatment:

Other: PD VitalOs cement®

Other: Hydroxyapatite bone graft

Other: biodegardable collagen membrane